Femasys stock.

Femasys Inc. (NASDAQ: FEMY) shares are trading higher Friday after HC Wainwright maintained a Buy rating on the stock and raised its price target from $5 to $13.Oct 24, 2023 · Femasys is a commercial-stage company with four approved products — FemaSeed (intratubal Insemination), FemVue (contrast generating device), FemCath (selective delivery catheter) and FemCerv ... With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Femasys saw a decline in short interest in November. As of November 15th, there was short interest totaling 286,700 shares, a decline of 33.0% from the previous total of 427,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will ...

Ratings analysis incomplete due to data availability. Recommendations not provided. Maximize Income Goal. See Best High Dividend Stocks Model Portfolio for our ...News All Videos Press Releases Conversation Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer -- Thought leader from top …Web

The stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Femasys: Other Events, Financial Statements And Exhibits. November 28, 2023 U.S. Securities and Exchange Commission. Item 8.01 Other Events On November 28, 2023, Femasys Inc. (the “Company”) announced the completion of enrollment in pivotal trial of its intratubal insemination product FemaSeed. A copy of the press release is being …Stock analysis for Femasys Inc (FEMY:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Get the latest Femasys Inc. (FEMY) stock news and headlines to help you in your trading and investing decisions.

Under the terms of the investment, the investors were also issued two series of warrants: warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.18 per share expiring one year from issuance and warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.475 per …

Invest in Femasys, NASDAQ: FEMY Stock - View real-time FEMY price charts. Online commission-free investing in Femasys: buy or sell Femasys Stock ...

View Our Latest Stock Analysis on FEMY. Femasys Price Performance. FEMY opened at $0.96 on Monday. The business has a fifty day moving average of $1.25 and a 200 day moving average of $0.81. Femasys has a 52-week low of $0.25 and a 52-week high of $4.75. The company has a quick ratio of 8.28, a current ratio of 4.68 and a …Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch - Topline results from FemaSeed® pivotal trial expected in 1H 2024 - - …WebA few examples include why shares of Tharimmune (NASDAQ: THAR) and Femasys (NASDAQ: FEMY) stock are up, as well as the biggest pre-market stock movers for today. All of that info is available at ...On average, Wall Street analysts predict. that Femasys's share price could reach $9.00 by Nov 14, 2024. The average Femasys stock price prediction forecasts a potential upside of 821.19% from the current FEMY share price of $0.98. View Our Latest Stock Analysis on FEMY. Femasys Price Performance. FEMY opened at $0.96 on Monday. The business has a fifty day moving average of $1.25 and a 200 day moving average of $0.81. Femasys has a 52-week low of $0.25 and a 52-week high of $4.75. The company has a quick ratio of 8.28, a current ratio of 4.68 and a …Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.15 nov 2023 ... ... shares of common stock at $1.18 per share, expiring one year from issuance, and warrants to purchase approximately 5.8 million shares of ...

Our Vision. Femasys is working to provide next generation advancements to disrupt severely under-served areas in women’s health. Technological advancements in female reproductive health are long overdue, driving our focus in …Sep 29, 2023 · Femasys Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023. Nov. 14. CI. Earnings Flash (FEMY) FEMASYS Reports Q3 Revenue $86,186. Nov. 14. MT. Femasys Inc. announced that it expects to receive $6.85 million in funding from PharmaCyte Biotech, Inc. Nov. 13. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day.Femasys Inc. 2021 Employee Stock Purchase Plan, incorporated by reference to Exhibit 10.4 of the registrant’s Form S-1 filed May 14, 2021 10.3 Amended and Restated Employment Agreement, by and between Femasys Inc. and Kathy Lee-Sepsick, incorporated by reference to Exhibit 10.6 of the registrant’s Form S-1/A filed June 14, 2021Femasys : Corporate Presentation June 2023. Disrupting Convention in Women's Health Through Continuous Innovation. This Presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 relating to our business, operations and financial conditions, including but not limited to current ...Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA. Stock split history for Femasys since 2021.In a concurrent private placement, Femasys has also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 3,196,722 shares of common stock.

FEMY Femasys Bull Pennant On 7/13/2021 Jonestrading brokerage Initiated Coverage with a Buy rating and a $8.45 Price Target On 7/13/2021 Chardan Capital brokerage Initiated Coverage with a Buy rating and a $25.00 Price Target How do you explain such a big difference in valuation?

Publish : 04 Oct 2023, 07:17 PM Update : 04 Oct 2023, 07:17 PM. Femasys (NASDAQ: FEMY) stock is down 50% over night from highs. A reasonable bet would be that FEMY stock will continue to fall back to more reasonable levels. For, as far as we can see at least, this is a flurry of speculation producing far too much movement for the objective ...Femasys Inc. Common Stock (FEMY) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the …WebEmployees: 30. 3950 JOHNS CREEK COURT, SUITE 100, SUWANEE, GA 30024. 770-500-3910. femasys.com. Femasys Inc. focuses on women's healthcare market in the United States. The company develops permanent birth …Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in ...Our Mission. Femasys is a biomedical company focused on meeting women’s unmet needs worldwide by developing a broad portfolio of innovative product candidates and products that include minimally invasive, in-office technologies for reproductive health.Femasys Inc. Common Stock (FEMY) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the price that an... FEMY - Femasys Inc Stock Price and Quote. Nov-23-23 03:38PM. 20 Countries with the Highest Teenage Pregnancy Rates. (Insider Monkey) Nov-15-23 08:30AM. PharmaCyte Biotech Acquires $5 Million Stake in Emerging Womens Health Innovator Femasys, Inc. Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by ... Wall Street’s analysts know that buying low is part of a winning stock strategy, and they’ve been looking for stocks that are low – undervalued, and possibly hitting bottom. It’s the first step in an old formula for success, with the next, of course, being to sell high. Some recent picks from the analyst corps, pulled up via the TipRanks platform, may raise …Femasys Inc (NASDAQ:FEMY) trade information. Femasys Inc (FEMY) registered a -2.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.33% in intraday trading to $0.93 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -9.71%, and it has moved …

2 oct 2023 ... The Femasys Inc (NASDAQ: FEMY) stock kept rising on Monday following Friday's 96% rally as investor sentiment towards it remained bullish.

Femasys expects the resulting patent, when issued, will have an anticipated expiration in 2039, at the earliest. In October, Femasys regained compliance with Nasdaq’s minimum bid price requirement, after having received a notice on June 1, 2023 from Nasdaq that they were not in compliance with such requirement.

The past week has seen Femasys Inc. (FEMY), a company known for its work in the healthcare sector, experience fluctuations in its stock price. With a 52-week range of $0.2480 - $4.7500 and an average volume of 14,323,125, the stock's performance has been intriguing. Photo by Afif Ramdhasuma on Unsplash. Factors driving this week's …Get Femasys Inc (FEMY.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsFemasys has an analyst consensus of Strong Buy, with a price target consensus of $7.33, representing a 543.0% upside. In a report issued on September 26, JonesTrading also maintained a Buy rating ...Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in ...Detailed statistics for Femasys Inc. (FEMY) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Femasys Inc. (FEMY) ... The stock price has decreased by -20.16% in the last 52 weeks. The beta is -3.54, so Femasys's price volatility has been lower than the market average. Beta (1Y)Our Mission. Femasys is a biomedical company focused on meeting women’s unmet needs worldwide by developing a broad portfolio of innovative product candidates and products that include minimally invasive, in-office technologies for reproductive health.Complete Femasys Inc. stock information by Barron's. View real-time FEMY stock price and news, along with industry-best analysis.Nov. 30, 2023 5:40 PM ET Femasys Inc. (FEMY) By: Tiyashi Datta, SA News Editor. Femasys ( NASDAQ: FEMY) filed a prospectus related to the offer and resale by the selling stockholders of up to an ...Femasys (FEMY) Short Interest Ratio and Volume 2023. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow. Important info on NVDA trade (Ad) 12 crew members are missing, 1 dead after a cargo ship sinks off a Greek island in stormy seas.Aug 10, 2023 · Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2023 and Provides Corporate Update. August 10, 2023 08:00 ET ... Common stock, $.001 par, 200,000,000 authorized, ...

On average, Wall Street analysts predict. that Femasys's share price could reach $9.00 by Nov 14, 2024. The average Femasys stock price prediction forecasts a potential upside of 821.19% from the current FEMY share price of $0.98.Femasys' cash burn of US$10.0m is about 50% of its US$20m market capitalisation. ... and we've picked out 3 warning signs for Femasys that investors should know when investing in the stock. ...Sep 26, 2023 · That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ... At Femasys Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Instagram:https://instagram. why is nvda stock downmicro e mini futures brokerssunnoconewest etfs Femasys Inc. Common Stock (FEMY) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical OfficerWeb wendy salesbest forex trading platform in usa The Zacks Consensus Estimate for Femasys’ sales in the third quarter of 2023 is pegged at $0.4 million. However, sales in the United States declined year over year in the second quarter of 2023 ... nyse pri Femasys Inc (NASDAQ:FEMY) trade information. Femasys Inc (FEMY) registered a -2.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.33% in intraday trading to $0.93 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -9.71%, and it has moved …Discover historical prices for FEMY stock on Yahoo Finance. View daily, weekly or monthly format back to when Femasys Inc. stock was issued. ... Femasys Inc. (FEMY) NasdaqCM - NasdaqCM Real Time ...